Integrative experimental and network pharmacology analysis reveals Madhunashini as a PAI-1–targeting therapeutic candidate for triple-negative breast cancer associated with diabetes

Planetary and Space Science · Elsevier

Аннотация

Publication date: August 2026 Source: European Journal of Medicinal Chemistry Reports, Volume 17 Author(s): Kadabagere Narayanaswamy Hemavathi, Sushil Kumar Middha, Ravishankar Pervaje, Thottethodi Subramanya Keshava Prasad, Shobha Dagamajalu

Читать у издателя →

Похожие статьи